Epicore Biosystems
Private Company
Total funding raised: $12M
Overview
Epicore Biosystems is pioneering the use of sweat as a diagnostic fluid through its proprietary wearable microfluidic sensor platform. The company has developed three primary solution areas: a real-time monitor for industrial heat stress and hydration (CH), a performance tracker for athletes (GX), and an FDA-registered collection system for clinical research (DP). As a private company, Epicore is leveraging partnerships with pharmaceutical firms, military organizations, and universities to validate its technology and expand into new applications like maternal health and muscle fatigue, positioning itself at the intersection of digital health, personalized monitoring, and non-invasive diagnostics.
Technology Platform
Wearable microfluidic sweat sensors that continuously capture and analyze biomarkers (electrolytes, metabolites) in sweat, integrated with skin temperature and motion data for personalized health and performance insights.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Epicore competes in the broader wearable biosensor market against large consumer electronics firms (e.g., Apple, Fitbit) offering general wellness metrics and specialized sports tech companies. Its primary differentiation is its focus on continuous, molecular-level sweat analysis via microfluidics, a more complex approach than typical optical heart rate or activity sensors. In clinical research, it competes with other specialized sweat collection devices.